These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1966813)

  • 1. Cooperation between tumor necrosis factor (TNF) and platelet-activating factor (PAF) in the inflammatory response.
    Maestre C; Zarco P; Gómez-Guerrero C; González E; Herrero-Beaumont G; Braquet M; Egido J
    J Lipid Mediat; 1990; 2 Suppl():S151-9. PubMed ID: 1966813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor alpha 'primes' the platelet-activating factor-induced superoxide production by human neutrophils: possible involvement of G proteins.
    Paubert-Braquet M; Hosford D; Klotz P; Guilbaud J; Braquet P
    J Lipid Mediat; 1990; 2 Suppl():S1-4. PubMed ID: 1966810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of platelet-activating factor and tumour necrosis factor in the pathogenesis of joint inflammation in rabbits.
    Zarco P; Maestre C; Herrero-Beaumont G; González E; Garcia-Hoyo R; Navarro FJ; Braquet P; Egido J
    Clin Exp Immunol; 1992 May; 88(2):318-23. PubMed ID: 1315229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes.
    Földes-Filep E; Braquet P; Filep J
    Biochem Biophys Res Commun; 1987 Nov; 148(3):1412-7. PubMed ID: 2825685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage.
    Vercellotti GM; Yin HQ; Gustafson KS; Nelson RD; Jacob HS
    Blood; 1988 Apr; 71(4):1100-7. PubMed ID: 2451547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats.
    Gómez-Chiarri M; Ortíz A; Lerma JL; López-Armada MJ; Mampaso F; González E; Egido J
    Lab Invest; 1994 Apr; 70(4):449-59. PubMed ID: 8176885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of platelet-activating factor on tumor necrosis factor-induced superoxide generation from human neutrophils. Possible involvement of G proteins.
    Braquet P; Hosford D; Koltz P; Guilbaud J; Paubert-Braquet M
    Lipids; 1991 Dec; 26(12):1071-5. PubMed ID: 1668107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.
    Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR
    Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages.
    Stewart AG; Dusting GJ
    Br J Pharmacol; 1988 Aug; 94(4):1225-33. PubMed ID: 2850058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor induces enhanced responses to platelet-activating factor and differentiation in human monocytic Mono Mac 6 cells.
    Weber C; Aepfelbacher M; Haag H; Ziegler-Heitbrock HW; Weber PC
    Eur J Immunol; 1993 Apr; 23(4):852-9. PubMed ID: 7681399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor stimulates interleukin-6 production by human endothelial cells and synergizes with tumor necrosis factor for enhanced production of granulocyte-macrophage colony stimulating factor.
    Lacasse C; Turcotte S; Gingras D; Stankova J; Rola-Pleszczynski M
    Inflammation; 1997 Apr; 21(2):145-58. PubMed ID: 9187959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
    Baroggi N; Etienne A; Braquet P
    Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro.
    Hirafuji M; Shinoda H
    Br J Pharmacol; 1991 Jun; 103(2):1333-8. PubMed ID: 1884095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
    Kurihara K; Wardlaw AJ; Moqbel R; Kay AB
    J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of platelet-activating factor in endotoxin-induced priming of rabbit polymorphonuclear leukocytes.
    Stewart AG; Harris T
    J Lipid Mediat; 1991; 3(2):125-38. PubMed ID: 1665713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of PAF in the allergic pleurisy caused by ovalbumin in actively sensitized rats.
    Martins MA; Castro Faria Neto HC; Bozza PT; e Silva PM; Lima MC; Cordeiro RS; Vargaftig BB
    J Leukoc Biol; 1993 Jan; 53(1):104-11. PubMed ID: 8381149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The accumulation of platelet activating factor in the injured cornea may be interrelated with the synthesis of lipoxygenase products.
    Bazan HE; Reddy ST; Woodland JM; Bazan NG
    Biochem Biophys Res Commun; 1987 Dec; 149(3):915-20. PubMed ID: 2827658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory effect of a PAF receptor antagonist and a new molecule with antiproteinase activity in an experimental model of acute urate crystal arthritis.
    Miguélez R; Palacios I; Navarro F; Gutierrez S; Sanchez-Pernaute O; Egido J; González E; Herrero-Beaumont G
    J Lipid Mediat Cell Signal; 1996 Jan; 13(1):35-49. PubMed ID: 8821809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elvax as a slow-release delivery agent for a platelet-activating factor receptor agonist and antagonist.
    Bix GJ; Clark GD
    J Neurosci Methods; 1997 Nov; 77(1):67-74. PubMed ID: 9402559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor potentiates interleukin-1/epidermal cell-derived thymocyte-activating factor release by guinea-pig keratinocytes stimulated with lipopolysaccharide.
    Pignol B; Lonchampt MO; Chabrier PE; Mencia-Huerta JM; Braquet P
    J Lipid Mediat; 1990; 2 Suppl():S83-91. PubMed ID: 2133287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.